Immunotherapy and the Standard of Cure
The mission of the Immunotherapy Institute of the Cancer Center at BIDMC is to:
- Develop powerful new immune-based cancer therapies through basic science, translational research and clinical trials
- Advance the development of personalized cell therapies and activation of the immune system by targeting the tumor microenvironment
- Develop immune-based therapies to significantly improve outcomes for cancer patients
- Move from the standard of care toward the standard of cure
As an international leader in cancer immunotherapy, the BIDMC Cancer Center in partnership with the BIDMC Cancer Research Institute is dramatically impacting scientific discovery and patient care through the transformative field of immunotherapy.
More About the Cancer Research Institute